Jim Weinstein, MD - 2020 World Medical Innovation Forum
James Weinstein DO, President and CEO D-H
This speaker appears at this event:

This speaker’s events are being finalized

Jim Weinstein, MD

    • SVP, Microsoft

Dr. James N. Weinstein is the Senior Vice President for Microsoft Health Care. He helps lead Strategic Partnerships across the health care ecosystem and remains focused on Innovation and Health Equity. Prior to joining Microsoft, he was the Chief Executive Officer and President of Dartmouth-Hitchcock Health. As leader of a bi-state health system, he created an operating model based in population health and transitioned the region from fee-for-service toward more global payments, value-based care. This became an important part of the national strategy during the Obama presidency. He built partnerships with a variety of providers throughout northern New England and throughout the United States, to deliver optimum care at lowest cost to patients. Prior to becoming CEO in 2011, Dr. Weinstein served as President of Dartmouth-Hitchcock Clinic, leader of the 1500 plus physicians across the Dartmouth Hitchcock system; held the Peggy Thompson Chair at the Geisel School of Medicine and; was the Director of The Dartmouth Institute for Health Policy and Clinical Practice (TDI), home of the Dartmouth Atlas of Health Care. For decades, the Atlas documented the ongoing variations in health care delivery across the United States and, has been part of several. U.S. Presidential health policy agendas. His dual positions as Clinic President and TDI Director allowed him to build critical linkages between, the groundbreaking health services research at TDI, and the clinical care teams at Dartmouth and nationally. During his tenure as CEO/President, Dartmouth Hitchcock Health grew from a one hospital, academic medical center, to a multi-hospital holding company including several critical access hospitals and, a State of the Art, Hospice Center. The local VNA network, joined the health system and was integral in supporting care transitions, supporting hospital at home and helped to round out a population health ecosystem.

While Director of TDI, Dr. Weinstein co-founded, with then Dartmouth College President Jim Yong Kim (immediate past President, World Bank); the Master of Health Care Delivery Science (MHCDS) program, a collaboration between TDI and the Tuck School of Business, the first hybrid residential and distance learning degree program offered by Dartmouth college. Earlier in his time at Dartmouth, Dr Weinstein was the inaugural Chair of Orthopedics and established, the first ever, Center for Shared Decision Making, allowing for true informed choice vs. more traditional informed consent, a true Patient/Consumer focus. This work was featured in the WSJ, and Washington Post. Dr Weinstein remains a strong advocate for what he calls “informed choice”, which requires SDM. He’s leadership in advancing “informed choice”, vs. traditional informed consent, was to ensure patients receive evidence-based, safe, effective, care; only the care they want/need, when well informed. This became part of the legal basis for patient informed choice, informed consent. Several states have since adopted this model and was part of the ACA.

Dr. Weinstein was the co-founder/Executive Director, the High Value Healthcare Collaborative (HVHC) involving 70 million patients, 70,000 physicians, across 31 states. The HVHC founding members included Mayo Clinic, Intermountain Healthcare, TDI, Denver Health, Geisinger and Cleveland Clinic. It grew to be a national partnership of more than a dozen health systems dedicated to improving the quality of care while lowering costs. The Collaborative allowed for unprecedented data sharing, including electronic medical record data from each system, and the first national collection of patient-reported measures (PRO’s). Dr Weinstein initiated PRO’s in 1982, while a resident at Rush Medical Center, Chicago and later at the University of Iowa Hospitals and Clinics, where he held an endowed chair until moving to Dartmouth. There, he recreated the multidisciplinary Spine Center which incorporated PRO’s, eventually adopted by ONC, (office of the national coordinator) as part of federally mandated, meaningful use data, part of value-based care. PRO’s were first automated, real time, while at the Dartmouth-Hitchcock Spine Center and eventually adopted by EPIC (Medical Record Co, Madison, Wisc.). Today, CMS, 21st Century cures act, is requiring direct to patients data, e.g., MyHealthEData, via using FHIR (Fast HealthCare Interoperability Resources) based API’s (Application Programming Interfaces) in clinical practice Patient Access, Blue Button 2.0. Microsoft is helping to lead these efforts.

As a researcher and internationally renowned spine surgeon, Dr. Weinstein received two Kappa Delta awards from the American Academy of Orthopedics (Nobel-like for the Orthopedics community), one for his basic research, neurophysiological understanding of pain; re., animal models of radiculopathy, while at Iowa (supported by the prestigious, 5 year, Bristol-Meyers Career Investigator Award); and the other for his Clinical Trials work as PI, of the 15 year NIH funded SPORT trial, the largest multi-state NIH supported clinical research program. It involved eleven states, more than 140 clinicians, enrolled (3,500) patients in this uniquely designed study (simultaneous, RCT and OBS) which used SDM as part of consent and collected PRO’s. Dr Weinstein founded multidisciplinary care teams, e.g., Spine Center first while at the University of Iowa and then at Dartmouth-Hitchcock. Today, such multidisciplinary centers, in varied fields, e.g., Cancer have become standard around the world, as care pathways. Clinically, he developed the first classification and treatment system by which surgeons around the world treat cancers of the spine. He has been a well-funded researcher throughout his career, receiving more than $70 million in federal funding (NIH, CMMI) and has published more than 335 peer-reviewed articles.

Upon retiring as CEO/President, he was appointed as a Senior Fellow, for the HealthCare Initiative, TUCK Business School at Dartmouth, a visiting Professor at the Northwestern Kellogg Business School, Public & Private Interface initiative. At Kellogg he teaches in the spring quarter, “The CEO Playbook for Health System Success”. He continues facilitating Dartmouth Hitchcock, Spine Center case study for Michael Porter and Rob Huckman at the Harvard Business School.

In 2015, Dr. Weinstein co-developed ImagineCare, a virtual health care system that incorporates 24/7 connectivity to manage chronic diseases outside the traditional bricks and mortar of traditional hospital-based systems. ImagineCare is currently being implemented in Scandinavia. Before leaving Dartmouth, he helped establish the Advanced Regenerative Manufacturing Institute (ARMI) which is supported by an $80 million grant from the Department of Defense (DOD) and more than $300 million in private sector funding (Dean Kamen PI). ARMI will use 3D technology to print human organs, from one’s own stem cells, a development that could transform the world of organ transplantation as we know it. The impact on lives of millions of people around the world could be affected by diseases of the kidney, diabetes and more.

Dr Weinstein is a member of the National Academy of Medicine – NAM and serves on the organization’s Board for Population Health and Public Health Practice. He served as Chair of the NAM; Committee on Community Based Solutions to Promote Health Equity in the U.S, which published the report, “Communities in Action: Pathways to Health Equity 2016. Today he serves on two NAM committees related to AI (artificial intelligence) in Health Care and Co-Chairs with NAM president Dr Victor Dzau the ongoing inequities in health care, ‘call to action’ meetings. He serves on several Boards of Trustees including the internationally renowned Max Planck Institute for Neuroscience, the DOD ARMI/BioFab project and the Intermountain Health System as well as several for profit and non for profits. Dr. Weinstein continues to serve as an appointee to the Special Medical Advisory Group of the VA, which advises the Secretary of Veterans Affairs and the Under Secretary for Health on matters relating to the care and treatment of veterans. He served on a special task force to assist in the reorganization of the active Military Health System, Army, Navy, Marines, Airforce and Tri-Care. He is frequently consulted by members of Congress and the Administration, as well as government leaders, on health policy and health reform. In 2015, Dr. Weinstein was awarded the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations. In 2017 he was the recipient of the prestigious American Hospital Association’s, Justin Ford Kimball Innovator’s Award. He has been named one of “The 100 Most Influential People in Healthcare” by Modern Healthcare magazine and top 50 “Physician Leaders to Know” by Becker’s Hospital Review. He is the longest standing Editor-in-Chief of a major journal, SPINE. His book, Unraveled: Prescriptions to Repair a Broken Health Care System, was published in February 2016, has received praise from health leaders and patients from around the world.

Gene and Cell Therapy

May 10–12, 2021